Purpose To determine the genetic basis of early onset autosomal recessive Best vitelliform macular dystrophy (arBVMD) in a family with three affected children. Design Clinical and family-based genetic study. Methods Seven subjects making up a family with three children affected by Best vitelliform macular dystrophy were studied. Standard ophthalmic exam with dilated ophthalmoscopy and imaging were performed in each individual. The eleven exons of BEST1 were directly sequenced. Results All three affected children have the clinical characteristic features of Best vitelliform macular dystrophy: large macular vitelliform lesions, scattered vitelliform lesions along the arcades and in the peripheral retina, and an accumulation of serous retinal fluid. A novel compound heterozygous mutation in the BEST1 gene was found in the three affected individuals (L41P and I201T). The unaffected parents and children only harbor one heterozygous mutation. Conclusion arBVMD can be caused by the compound heterozygous mutation L41P and I201T in the BEST1 gene.
Introduction
Autosomal dominant Best vitelliform macular dystrophy (BVMD) is one of the most common retinal dystrophies. The disease is characterized clinically by deposition of yellowish material in the retinal pigment epithelium (RPE) and subretinal space. This accumulated material forms the characteristic egg yolk-like appearance in the macula. While the autosomal dominant pattern of inheritance has been long observed, an autosomal recessive pattern has also been reported recently. 1 Homozygous or compound mutations in the BEST1 gene can cause autosomal recessive BVMD (arBVMD). [1] [2] [3] [4] [5] [6] BEST1 is located on chromosome 11q13 and encodes the bestrophin-1 protein that localizes to the RPE. 1, 7, 8 The exact function of the bestrophin protein is not completely understood. However, it has been suggested that bestrophin-1 acts as either a chloride channel or a modulator of calcium channels. 6, [8] [9] [10] To date, several mutations in arBVMD cases have been reported. [1] [2] [3] 5, 11, 12 These include homozygous and combinations of nonsense or missense mutations. In all of these cases, patients presented with central vision loss, characteristic retinopathy, absence of electro-oculogram light rise, and a reduced electroretinogram. 1 In this report, we present a novel compound heterozygous mutation in a family with three affected children.
Materials and methods

Participants and clinical examinations
The family being studied consisted of seven individuals, including two parents and five children. Three of the children complained of visual impairment. The parents and two of the children denied any visual symptoms. Both of the parents, the three affected children, and two non-affected children had their blood drawn for genetic analysis.
Each family member received a complete ophthalmic examination. Exams included best-corrected visual acuity measurements and applanation tonometry for intraocular pressure measurements. Slit lamp exams included fundus biomicroscopy. In addition, fundus photography and spectral domain optical coherence tomography were completed.
DNA sequencing
Genomic DNA samples were extracted from peripheral blood leukocytes according to established protocols from seven of the family members. Direct DNA sequence analysis was completed for the BEST1 gene. The eleven exons of the BEST1 gene were amplified by PCR and sequenced using the Genetic Analyzer 3130 system (Applied Biosystems, Foster City, CA, USA). Primers used to amplify the exons in the BEST1 gene are presented (Table 1) .
Results
Clinical examinations
The family under study consisted of seven individuals, including two non-consanguineous Caucasian parents and five children. Three of the five children were diagnosed with arBVMD at age 4.
Child 1 (II-1 in Figure 1a ) is a twelve-year-old female with best-corrected visual acuities of 20/400 OD and 20/30 OS. Dilated ophthalmic exam is significant for macular lesions and smaller scattered vitelliform lesions in the periphery of the right eye, intraretinal cysts, and elevation and separation of the neurosensory retina from the RPE in the left eye ( Figure 2 ).
Child 3 (II-3 in Figure 1a ) is a nine-year-old male with best-corrected visual acuities of 20/30 OD and 20/40 OS. Dilated ophthalmic exam is significant for scattered vitelliform lesions, subretinal deposits, and subretinal fluid in the macula of the right eye ( Figure 3 ).
Child 4 (II-4 in Figure 1a ) is a five-year-old female with best-corrected visual acuities of 20/40 OD and 20/30 OS. Dilated ophthalmic exam is significant for bilateral yellowish, subretinal macular lesions with the lesion in the right eye extending outside the macular area down to the inferior arcade. There are some small deposits noted in the left macula and serous retinal fluid in both eyes.
The parents (I-1 and I-2) and the other two unaffected children (II-2 and II-5) have no clinical signs of disease ( Figure 4 ).
Genetic analysis
The family history is consistent with an autosomal recessive inheritance pattern ( Figure 1a) . We found the unaffected father to have a T4C transition (c.122T4C) in exon 5, resulting in a L41P substitution (Figure 1b) . The unaffected mother, however, was found to have a different variation, consisting of a T4C transition (c.602T4C) in exon 2, resulting in an I201T substitution (Figure 1c) . The three affected children harbor both of these variations while the two unaffected children carry only one of the heterozygous mutations. Table 2 summarizes the genetic analysis results for each family member. These two changes were absent in 1000 normal control chromosomes.
Discussion
We report a family with an autosomal recessive BVMD that resulted from compound heterozygous BEST1 mutations. 1 In these cases, the unaffected family members carry only one of the heterozygous mutations. While over 100 different BEST1 mutations have been CCATGGCCCCTCTAATTTCT  363  2  GAGGTCCAGAGCAGGGAAGGGT  CAGCCCCAGCCACATCCTT  327  3  GAGGCAGTCCCACTCCTACC  GCAGCTCCTCGTGATCCTC  278  4  CTCCTGCCCAGGCTTCTACGT  CCACCCATCTTCCATTCCT  326  5  GGTTCCTATAGGTCAGCAGGTG  GAAACCTTGTTTCCTGTGGAC  303  6  TGGTACCTGGAGAAGAGGTG  CCTTGGTCCTTCTAGCCTCA  219  7  CATCCTGATTTCAGGGTTCC  GACACTGCATCCTCGTCTCA  298  8  ATGGGGTGTGGAAATAGCAG  GAGGGGAAGGGTTGATCATT  290  9  CTCCAAGTCATCAGGCACAT  GCAGACCCCTGCACTAGGAG  284  10-1  GGTGTTGGTCCTTTGTCCAC  TGACACTGTGAAGCTTTGACG  430  10-2  CTGGAAGCTTAAGGCTGTGG  TAGGCTCAGAGCAAGGGAAG  481  11  CTTTGCCCTCCTACTGCAAC  TCCTTAAGTGCCGTTGTTCA  487 described in families affected by Best disease, [13] [14] [15] [16] [17] only a few combinations of compound heterozygous mutations in arBVMD have been reported. [1] [2] [3] [4] [5] 11 In our study, the affected children were found to have a combination of two heterozygous mutations: c.122T4C (L41P) and c. 602T4C (I201T). The L41P mutation has 1 The I201T mutation has also been implicated in arBVMD. To date, three individual cases of a compound heterozygous mutation with I201T have been reported: I201T with P152A, I201T with IVS 7 þ 4G4A, and I201T with the deletion Phe281del3CAGTTC. 1 We have shown for the first time that the combination of I201T with L41P can also lead to arBVMD.
In vitro studies using HEK293 cells have shown that co-transfection of the two mutations observed in the compound heterozygous state in arBVMD patients essentially abolished chloride channel activity. However, when six arBVMD mutations were coexpressed with wild-type bestrophin-1, none of the combinations suppressed the wild-type chloride channel activity. 1 Therefore, it is suggested that the autosomal recessive phenotype only manifests when the bestrophin-1 activity drops below a functional threshold. 1, 18 The mutations that make up the autosomal recessive phenotype do not cause enough structural change in the protein to bring its function below threshold alone in the carrier. They must be combined with other mutations to affect protein function.
The phenotype of BVMD varies with each patient and the stage of the disease. Initial stages are characterized by a circular or horizontally elliptical vitelliform lesion centered around the fovea and ranging in diameter from 0.5 disk diameter to 2 disk diameters, simulating the appearance of an egg yolk. 19 Over the years, the material in the subretinal space may become less homogenous, giving rise to what is known as the 'scrambled-egg' stage, or it may gravitate inferiorly, forming the 'pseudohypopyon' stage. 20 Previous publications have discussed that the clinical presentation of cases of compound arBVMD are noticeably different from the autosomal dominant form. 1, 11, 13 The most-reported distinguishing feature of arBVMD is extrafoveal and extramacular subretinal deposits.
Additionally, patients with BVMD are at increased risk for choroidal neovascularization. These membranes are often difficult to detect owing to the overlying vitelliform lesions. 3 There have been several reports of favorable outcomes with the use of anti-VEGF therapy. 21, 22 This has turned out to be consistent with our study, where the patients' sub-or intraretinal fluid has resolved from injections of bevacizumab.
Our finding adds to the spectrum of clinical presentations caused by BEST1 mutations. Understanding the genetics of the bestrophinopathies and the cause of different forms of the disease will allow for the development of potential gene therapy regimens and new diagnostic modalities.
